Why is Intuitive Surgical stock up 4.3% today?

Traders Union
All News
Stocks
Intuitive surgical rises 4.35% today

Highlights

Intuitive Surgical exceeded quarterly earnings expectations, fueled by a 19% revenue surge from increased procedures and recurring service income.
Company insiders recorded 34 open market trades over six months, signaling sustained internal activity following robust operational results.
Despite solid earnings, the stock trades below key averages with momentum indicators bearish and a high probability of a decline toward $356.59–$385.04 over the next week.

Earnings beat and insider trades drive renewed bullish sentiment

Intuitive Surgical reported quarterly earnings that surpassed expectations, driven by a nearly 19% increase in revenue. This growth was attributed to rising procedure volumes for its surgical systems and higher recurring revenue from instrument and maintenance services, including recent award payments of $272,040 for the da Vinci robot platform. Company insiders conducted 34 open market trades in the past six months, highlighting continued internal activity following these results.

Anton Kharitonov, expert at Traders Union, notes that Intuitive Surgical’s strong quarterly results sparked only a short-lived rebound. He highlights the technical setup as decisively bearish, with the stock trading below all key moving averages and facing persistent seller pressure. Kharitonov observes that mild oversold signals have not attracted sustained buying interest, and momentum indicators remain weak. He points to ongoing insider trading as a sign of internal uncertainty despite headline revenue gains. "Investors should remain cautious — downward momentum shows no convincing sign of reversal yet."

Viktoras Karapetjanc, expert at Traders Union, sees the earnings beat and double-digit revenue growth as major positives for Intuitive Surgical. He believes surging procedure volumes and recurring service revenues reinforce the company’s long-term bullish structure. Karapetjanc highlights significant internal activity by company insiders as a vote of confidence. In his view, further growth opportunities arise as the market absorbs strong results and resets technical levels. "Strong fundamentals and solid business trends pave the way for future upside in ISRG."

Sholanke Dele, market strategist, emphasizes bearish sentiment around Intuitive Surgical after the initial surge. He points to the stock’s failure to sustain gains above support and the session close near lows as signs of weak conviction. Dele notes that intraday seller dominance signals traders’ lack of enthusiasm despite positive news. "Without a catalyst for sustained buying, downside risk remains the dominant narrative here."

Seller pressure extends as technicals confirm weak momentum

Intuitive Surgical is trading below its 20-day, 50-day, and 200-day moving averages at $375.53, $399.40, and $481.88, confirming persistent seller control and a bearish alignment across all timeframes. The nearest resistance is at $374.70 and support at $370.08, with the Ichimoku Kijun at $386.21 reinforcing the downside momentum. Momentum signals are weak, as the MACD indicates continued selling and the ADX is neutral, reflecting a lack of strong trend direction. The RSI at 40.99 and CCI at -53.22 suggest mild oversold conditions, while the Bull/Bear Power at -5.26 highlights intraday seller dominance. Stochastic RSI and the Awesome Oscillator show flattening momentum, and the stock is trading near session lows after an early upside gap.

Earlier, analysts noted that Intuitive Surgical remained under sustained downside pressure, with technical indicators and sentiment reflecting limited prospects for a near-term recovery. Although today's earnings-led rebound offers short-term support, the persistence of bearish momentum suggests traders should closely monitor whether the stock can decisively break above its immediate resistance to signal a potential shift in trend.

Source of Data: ISRG Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.